IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.627
EU - Europa 12.390
AS - Asia 11.860
SA - Sud America 1.966
Continente sconosciuto - Info sul continente non disponibili 771
AF - Africa 316
OC - Oceania 78
Totale 54.008
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.200
CN - Cina 4.252
PL - Polonia 3.958
SG - Singapore 3.741
UA - Ucraina 2.111
BR - Brasile 1.611
DE - Germania 1.496
IT - Italia 1.361
HK - Hong Kong 1.265
VN - Vietnam 809
FI - Finlandia 795
GB - Regno Unito 650
FR - Francia 557
RU - Federazione Russa 415
IN - India 406
TR - Turchia 403
IE - Irlanda 373
BD - Bangladesh 313
CA - Canada 211
SE - Svezia 118
AR - Argentina 114
ZA - Sudafrica 112
MX - Messico 110
CZ - Repubblica Ceca 102
NL - Olanda 102
ES - Italia 100
JP - Giappone 98
ID - Indonesia 96
IQ - Iraq 77
AU - Australia 69
EC - Ecuador 64
PK - Pakistan 52
MA - Marocco 47
CO - Colombia 45
AT - Austria 43
IR - Iran 43
BE - Belgio 41
VE - Venezuela 41
SA - Arabia Saudita 38
CL - Cile 33
KE - Kenya 30
JM - Giamaica 28
NG - Nigeria 26
UZ - Uzbekistan 26
CH - Svizzera 24
LT - Lituania 22
PE - Perù 22
AZ - Azerbaigian 20
MU - Mauritius 20
EU - Europa 19
IL - Israele 19
JO - Giordania 19
MY - Malesia 18
AE - Emirati Arabi Uniti 17
PH - Filippine 17
PY - Paraguay 17
EG - Egitto 16
KR - Corea 16
TN - Tunisia 16
TH - Thailandia 15
DZ - Algeria 14
KZ - Kazakistan 14
BG - Bulgaria 13
PA - Panama 13
RO - Romania 13
NO - Norvegia 11
HU - Ungheria 10
NP - Nepal 10
TW - Taiwan 10
CR - Costa Rica 9
ET - Etiopia 9
KG - Kirghizistan 9
UY - Uruguay 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
GE - Georgia 8
GR - Grecia 8
LK - Sri Lanka 8
LV - Lettonia 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
CU - Cuba 7
DK - Danimarca 7
HN - Honduras 7
HR - Croazia 7
LB - Libano 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
NZ - Nuova Zelanda 6
AL - Albania 5
SV - El Salvador 5
BH - Bahrain 4
BY - Bielorussia 4
EE - Estonia 4
RS - Serbia 4
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
BZ - Belize 3
Totale 53.187
Salva come PNG Salva come JPEG
Città #
Warsaw 3.948
Fairfield 3.027
Ashburn 2.397
Woodbridge 2.187
Singapore 1.982
Jacksonville 1.582
Houston 1.520
Hong Kong 1.251
Ann Arbor 1.180
Cambridge 1.173
San Jose 1.167
Seattle 1.105
Wilmington 1.062
Beijing 918
Chandler 798
The Dalles 732
Princeton 669
Nanjing 581
New York 527
Los Angeles 458
Helsinki 438
Brescia 392
Dublin 369
Dallas 353
Dearborn 337
Istanbul 305
Lauterbourg 303
Columbus 294
Council Bluffs 257
Ho Chi Minh City 224
Munich 223
Dong Ket 181
Nanchang 180
San Francisco 173
Buffalo 170
São Paulo 166
Moscow 160
Milan 159
Santa Clara 159
Des Moines 151
Shenyang 151
Hebei 144
Jinan 144
Chicago 142
Changsha 139
San Diego 138
Shanghai 138
Hanoi 126
Orem 112
Lancaster 106
Tianjin 106
Jiaxing 101
London 101
Redondo Beach 97
Phoenix 89
Tokyo 89
Boardman 79
Brooklyn 75
Kunming 73
Turku 69
Hangzhou 66
Jakarta 66
Brno 64
Chennai 64
San Mateo 61
Guangzhou 60
Rome 60
Johannesburg 57
Madrid 55
Verona 54
Boston 53
Montreal 52
Toronto 52
Porto Alegre 51
Atlanta 48
Haikou 48
Rio de Janeiro 46
Amsterdam 45
Denver 45
Zhengzhou 45
Ningbo 44
Augusta 43
Stockholm 43
Lanzhou 42
Nuremberg 42
Manchester 40
Mexico City 37
Belo Horizonte 36
Charlotte 36
Brussels 35
Kocaeli 35
Poplar 34
Washington 34
Leawood 33
Frankfurt am Main 31
Curitiba 29
Fuzhou 29
Mumbai 29
Dhaka 28
Haiphong 28
Totale 37.277
Salva come PNG Salva come JPEG
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 404
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 380
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 362
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 360
The nanostructured secretome 355
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 344
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 328
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 320
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 310
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 308
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 307
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 304
Claudin3 is localized outside the tight junctions in human carcinomas 298
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 295
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 293
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 293
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 290
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 290
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 286
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 286
Different effects of mucosal, beef lung, and chemically modified heparin on selected biological properties of basic fibroblast growth factor 282
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 282
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 282
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 281
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 281
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 280
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 276
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 276
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 274
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 273
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 268
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 260
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 258
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 258
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 254
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 254
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 249
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 242
Zebrafish disease models in hematology: Highlights on biological and translational impact 239
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 231
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 229
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 229
Long pentraxin-3 follows and modulates bladder cancer progression 224
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 222
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 218
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 216
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 215
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 215
Anti-angiogenic activity of the purine analog 6-thioguanine. 214
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 213
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 211
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 211
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 210
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 209
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 208
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 208
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 208
The zebrafish/tumor xenograft angiogenesis assay. 207
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 207
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 206
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 203
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 203
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 203
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 200
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 197
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 197
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 197
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 197
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 195
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 194
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 194
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 193
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 192
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 190
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 190
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 189
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 188
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 188
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 188
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 187
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 187
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 186
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 186
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 185
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 184
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 182
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 180
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 180
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 178
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 178
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 178
Beta-Galactosylceramidase deficiency: neurovascular implications 178
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 177
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 177
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 175
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 174
Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications 173
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 173
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 171
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 170
Totale 23.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 236.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 236.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.863 0 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20256.143 86 57 40 861 652 574 516 250 708 468 1.139 792
2025/202613.407 1.327 1.675 1.078 1.838 1.441 883 2.044 444 792 1.113 538 234
2026/20271.059 597 462 0 0 0 0 0 0 0 0 0 0
Totale 54.008